FWWMX
Price
$65.89
Change
-$0.01 (-0.02%)
Updated
Dec 26 closing price
Net Assets
209.48B
PNBCX
Price
$27.50
Change
-$0.03 (-0.11%)
Updated
Dec 26 closing price
Net Assets
286.71M
Interact to see
Advertisement

FWWMX vs PNBCX

Header iconFWWMX vs PNBCX Comparison
Open Charts FWWMX vs PNBCXBanner chart's image
American Funds Washington Mutual 529-F-3
Price$65.89
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets209.48B
Virtus NFJ Large-Cap Value C
Price$27.50
Change-$0.03 (-0.11%)
VolumeN/A
Net Assets286.71M
FWWMX vs PNBCX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FWWMX has more cash in the bank: 209B vs. PNBCX (287M). FWWMX pays higher dividends than PNBCX: FWWMX (1.38) vs PNBCX (0.54). FWWMX was incepted earlier than PNBCX: FWWMX (5 years) vs PNBCX (23 years). PNBCX (1.76) is less costly to investors than FWWMX (0.31). PNBCX is a more actively managed with annual turnover of: 41.00 vs. FWWMX (29.00). FWWMX has a lower initial minimum investment than PNBCX: FWWMX (250) vs PNBCX (2500). FWWMX annual gain was more profitable for investors over the last year : 6.12 vs. PNBCX (-2.82). FWWMX return over 5 years is better than : 45.39 vs. PNBCX (-3.29).
FWWMXPNBCXFWWMX / PNBCX
Total Expense Ratio0.311.7618%
Annual Report Gross Expense Ratio0.311.7618%
Fund Existence5 years23 years-
Gain YTD8.276-1.542-537%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets209B287M72,822%
Annual Yield % from dividends1.380.54257%
Returns for 1 year6.12-2.82-217%
Returns for 3 years33.0013.58243%
Returns for 5 years45.39-3.29-1,381%
Returns for 10 yearsN/A38.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGINX33.060.06
+0.18%
Invesco International Value Investor
USAUX76.150.06
+0.08%
Victory Aggressive Growth
SUFCX39.430.02
+0.05%
NAA Mid Growth C
VAFCX22.16-0.01
-0.05%
Invesco American Franchise C
BRSPX14.10-0.03
-0.21%
MFS Blended Research Small Cap Eq R1